Apply for funding

At APF, we provide grants for pulmonary fibrosis researchers to attend conferences so that they can learn, collaborate and network with international partners.

Aims of our conference grant programme

We aim to support researchers working towards finding a cure. APF provides young researchers the chance to develop their knowledge and strengthen their skills.

We currently provide travel or attendance grants for the following conferences:

Interested in applying?

European Respiratory Society (ERS) International Congress Attendance Awards

Action for Pulmonary Fibrosis would like to support researchers working in pulmonary fibrosis to attend the Virtual ERS International Congress 2021.  The awards of up to £200 contribute towards costs for conference registration.  We have four awards available.  These awards are made possible by the dedicated fundraising activities of the APF community.  

Applications are now invited from UK based students and early career researchers/HCPs who have had an abstract accepted for presentation (poster or spoken session) for the ERS.  Applications should be in the form of a brief (1-2 page) curriculum vitae, with a copy of the accepted abstract, and a covering letter detailing the reasons why attendance is of particular importance.  

Applications should be submitted by email to by 20th August, 2021.

Applications will be judged on the basis of scientific merit.

Successful applicants will be asked to write a lay report including a summary of the research they presented and their experiences at the ERS conference for publication on our website and social media channels.  Winners must acknowledge Action for Pulmonary Fibrosis in any presentations, posters, press releases or announcements related to their submitted abstract.

Reports by previous recipients

The following reports were written by previous recipients of travel subsidy grants (PDF and Word documents).

American Thoracic Society International Conference

European Respiratory Society (ERS) International Congress

International Colloquium on Lung and Airway Fibrosis (ICLAF)